Proove Opioid Response

Proove Biosciences has launched Proove Opioid Response, a clinical laboratory test to predict a patient's response to opioid pain medications. The test provides physicians information about which opioids a patient is likely to respond to and assesses 49 genetic variations for information about safety and effectiveness in five specific opioids — hydrocodone, oxycodone, morphine, tramadol, and hydromorphone.